Intuitive Surgical Beats Q1 Estimates, Raises 2026 Procedure Growth Outlook
Intuitive Surgical reported first-quarter 2026 revenue of $2.77 billion, up 23% from $2.25 billion a year earlier, while GAAP net income rose to $822 million, or $2.28 per diluted share, from $698 million, or $1.92 per diluted share. Non-GAAP net income was $901 million, or $2.50 per diluted share, and the quarter beat market expectations, with revenue above the $2.62 billion estimate and adjusted EPS above the $2.12 estimate.
Worldwide da Vinci and Ion procedures grew about 17% year over year, including 16% growth for da Vinci and 39% for Ion. The company raised its fiscal 2026 outlook for worldwide da Vinci procedure growth to about 13.5% to 15.5% and said it placed 431 da Vinci systems in the quarter, including 232 da Vinci 5 systems.
From the sources (4 posts)
@alphasenseinc$ISRG Earnings: - First quarter 2026 revenue of $2.77 billion increased 23%, compared with $2.25 billion in the first quarter of 2025. - First quarter 2026 GAAP net income attributable to Intuitive Surgical, Inc. was $822 million, or $2.28
@wallstengine$ISRG Q1’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $2.77B (Est. $2.62B) 🟢; +23% YoY 🔹 Adj. EPS: $2.50 (Est. $2.12) 🟢 🔹 Worldwide Procedures Growth: +17% YoY 🔹 da Vinci Procedures Growth: +16% YoY 🔹 Ion Procedures Growth: +39% YoY 🔹 da Vinci System
@thetranscript_Intuitive CEO: "We are pleased with company performance this quarter, which was marked by expanded adoption of our da Vinci, Ion & digital platforms" Q1 26: —Revenue: +23% YoY to $2.77B —Net Income: +17.8% YoY to $822M —da Vinci Instal
@businessIntuitive Surgical raised its fiscal 2026 outlook for use of its flagship surgical robotic system and reported first-quarter results that beat expectations, lifted by growing usage in the US and Europe